Drug Shortage Report for ALYSENA 21
| Report ID | 241066 |
| Drug Identification Number | 02387875 |
| Brand name | ALYSENA 21 |
| Common or Proper name | ALYSENA |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL LEVONORGESTREL |
| Strength(s) | 20MCG 100MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3X21 BLS |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-22 |
| Estimated end date | 2025-01-03 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-24 |
| Company comments | 3X28 BLS available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-10-24 | French | Compare |
| v1 | 2024-10-24 | English | Compare |
Showing 1 to 2 of 2